![Patrick Most](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Patrick Most is the founder of uniQure GmbH and AaviGen GmbH.
At uniQure GmbH, he held no specific title.
At AaviGen GmbH, he held the title of Chief Executive Officer & Co-Managing Director, but was no longer active in that role.
Actieve functies van Patrick Most
Bedrijven | Functie | Begin |
---|---|---|
uniQure GmbH
![]() uniQure GmbH BiotechnologyHealth Technology Part of uniQure NV, uniQure GmbH is a German company that provides research and development services of human gene-based therapies. The company is based in Heidelberg, Germany. The company was founded by Hugo Katus, Patrick Most. uniQure was acquired by uniQure NV on August 11, 2014 for $4.02 million. | Oprichter | - |
AaviGen GmbH
![]() AaviGen GmbH BiotechnologyHealth Technology AaviGen GmbH is a German pre-clinical biotechnology company that focuses on developing curative gene therapies. The company is based in Heidelberg, Germany. AaviGen was founded by Martin Busch, Marc Lerchenmueller, Hugo Katus, and Patrick Most. Patrick Most has been the CEO since incorporation. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
uniQure GmbH
![]() uniQure GmbH BiotechnologyHealth Technology Part of uniQure NV, uniQure GmbH is a German company that provides research and development services of human gene-based therapies. The company is based in Heidelberg, Germany. The company was founded by Hugo Katus, Patrick Most. uniQure was acquired by uniQure NV on August 11, 2014 for $4.02 million. | Health Technology |
AaviGen GmbH
![]() AaviGen GmbH BiotechnologyHealth Technology AaviGen GmbH is a German pre-clinical biotechnology company that focuses on developing curative gene therapies. The company is based in Heidelberg, Germany. AaviGen was founded by Martin Busch, Marc Lerchenmueller, Hugo Katus, and Patrick Most. Patrick Most has been the CEO since incorporation. | Health Technology |